ResearcherKagoshima UniversityActive in the last 2 years
Yuto Hozaka
Matched on ORCID iD 0000-0003-0655-4488; OpenAlex author ID A5001320462. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 8
- Personalizing CA125 Levels Using Tumor Marker Variants: A Case-Control Analysis of Diagnostic Performance for Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-25-1050↗
- Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17183090↗
- Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/mpa.0000000000002373↗
- Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis. Co-author DOI 10.21873/anticanres.15824↗
- Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma. First author DOI 10.21873/anticanres.15297↗
- Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis. Co-author DOI 10.3390/cancers13051057↗
- Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes. Co-author DOI 10.3390/cancers12102731↗
- Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. Co-author DOI 10.3390/ijms21186459↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tetsuya Idichi · 7 shared papers, 2020–2025 · strength 1.06
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090↗
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis. DOI 10.21873/anticanres.15824↗
- Takao Ohtsuka · 7 shared papers, 2020–2025 · strength 1.06
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090↗
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis. DOI 10.21873/anticanres.15824↗
- Hiroshi Kurahara · 6 shared papers, 2020–2024 · strength 0.79
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis. DOI 10.21873/anticanres.15824↗
- Paper Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retros… DOI 10.3390/cancers13051057↗
- Yuko Mataki · 4 shared papers, 2021–2025 · strength 0.72
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090↗
- Paper Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcino… DOI 10.1097/mpa.0000000000002373↗
- Paper Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis. DOI 10.21873/anticanres.15824↗
- Chieri Nakayama · 2 shared papers, 2022–2025 · strength 0.41
- Takako Tanaka · 3 shared papers, 2020–2021 · strength 0.34
- Paper Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15297↗
- Paper Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogen… DOI 10.3390/cancers12102731↗
- Paper Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. DOI 10.3390/ijms21186459↗
- Naohiko Seki · 3 shared papers, 2020–2021 · strength 0.34
- Paper Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15297↗
- Paper Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogen… DOI 10.3390/cancers12102731↗
- Paper Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. DOI 10.3390/ijms21186459↗
- Ryu Matsumoto · 1 shared paper, 2025 · strength 0.27
- Jin Peng He · 1 shared paper, 2025 · strength 0.25
- Masataka Hayashi · 1 shared paper, 2025 · strength 0.25
- Marcia Irene Canto · 1 shared paper, 2025 · strength 0.25
- Amanda L. Blackford · 1 shared paper, 2025 · strength 0.25
- Takeichi Yoshida · 1 shared paper, 2025 · strength 0.25
- Katsuya Hirose · 1 shared paper, 2025 · strength 0.25
- Michael Goggins · 1 shared paper, 2025 · strength 0.25
- Elham Afghani · 1 shared paper, 2025 · strength 0.25
- Hiroki Shimomura · 2 shared papers, 2020–2022 · strength 0.24
- Akihide Tanimoto · 1 shared paper, 2024 · strength 0.19
- Michiyo Higashi · 1 shared paper, 2024 · strength 0.19
- Kosuke Fukuda · 1 shared paper, 2024 · strength 0.19
- Hideyuki Oi · 1 shared paper, 2024 · strength 0.19
- Kosei Maemura · 1 shared paper, 2021 · strength 0.13
- Pramod Nepal · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.